Key result
Left ventricular outflow tract obstruction occurs in 10-25% of patients with tako-tsubo cardiomyopathy, potentially leading to cardiogenic shock or cardiac rupture.
Answers are grounded in this paper and cite their sources.
This editorial discusses the mechanisms of tako-tsubo cardiomyopathy and the potential use of cibenzoline for associated left ventricular outflow tract obstruction.
Some patients with tako-tsubo cardiomyopathy (TCM) develop cardiogenic shock or cardiac rupture due to left ventricular outflow tract (LVOT) obstruction [1–4]. LVOT obstruction is reported to occur in 10–25% of patients with TCM [5,6]. The exact mechanism of TCM is unknown. The trigger is frequently, but not always, an intense emotional or physical stress. The pathogenesis is not well understood but a number of theories exist; catecholamine drive, oxidative stress, estrogen deficiency, transient coronary artery spasm, or genetic predisposition.
No takes yet. Share an insight, caveat, or question.
Ryuichiro Anan (2015) conducted an editorial in Tako-tsubo cardiomyopathy and hypertrophic cardiomyopathy. Cibenzoline was evaluated. Left ventricular outflow tract obstruction occurs in 10-25% of patients with tako-tsubo cardiomyopathy, potentially leading to cardiogenic shock or cardiac rupture.
Synapse has enriched 10 related papers. Consider them for comparative context: